BackDuration: 10 minutes
3 in1 integrated test to confirm the diagnosis of acute myocardial injury/infarction
Clinical significance of test
cTnI: It is a contractile protein that exists only in the myocardium. It is one of the three subunits of troponin complex (I, T, C), and combines with tropomyosin in the filaments of myofibrils to form actin.
CK-MB: a form of creatine kinase isoenzyme, which mainly exists in the myocardium. It is one of the important markers of myocardial injury and can effectively diagnose acute myocardial infarction.
Myo: Mainly present in the myocardium and skeletal muscle. When skeletal muscle and myocardium are damaged (acute myocardial infarction), excessive exercise and muscle diseases, myoglobin is released into the blood. The levels of MYO can therefore not be used as a single diagnostic marker, but in conjunction with the troponins or CK-MB. Thus, serum levels of MYO can be used to rule out, rather than diagnose, myocardial infarction
Steps of operation
Clinical application
- Contribute to the early diagnosis and risk stratification of acute coronary syndrome
- Judging the area of myocardial ischemia injury
- Differential diagnosis of various causes of chest pain
- Monitoring of myocardial injury caused by various reasons
- Evaluation of clinical efficacy of certain therapeutic drugs
Interpretation of results
Contact us
